Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach

被引：12
|
作者：
Obando-Pereda, Gustavo [1 ]
机构：
[1] Univ Catolica Santa Maria, Prote Inflammat & Pain Lab, Urb San Jose S-N, Arequipa 04001, Peru
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 09期
关键词：
cytokine storm; macrophage; molecular mimicry; SARS-CoV-2; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; MACROPHAGE ACTIVATION; CD8(+) T; COVID-19; PROTEIN; PARP14; SEQUENCE; PEPTIDE;
D O I：
10.1002/jmv.27040
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
PARP14 and PARP9 play a key role in macrophage immune regulation. SARS-CoV-2 is an emerging viral disease that triggers hyper-inflammation known as a cytokine storm. In this study, using in silico tools, we hypothesize about the immunological phenomena of molecular mimicry between SARS-CoV-2 Nsp3 and the human PARP14 and PARP9. The results showed an epitope of SARS-CoV-2 Nsp3 protein that contains consensus sequences for both human PARP14 and PARP9 that are antigens for MHC Classes 1 and 2, which can potentially induce an immune response against human PARP14 and PARP9; while its depletion causes a hyper-inflammatory state in SARS-CoV-2 patients.
引用
收藏
页码：5350 / 5357
页数：8
相关论文
共 50 条
  • [31] Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
    Cappello, Francesco
    Gammazza, Antonella Marino
    Dieli, Francesco
    de Macario, Everly Conway
    Macario, Alberto J. L.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07)
  • [32] In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor
    Khan, Faez Iqbal
    Hassan, Fakhrul
    Lai, Dakun
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [33] Molecular Characterization of SARS-CoV-2
    Dermaku-Sopjani, Miribane
    Sopjani, Mentor
    CURRENT MOLECULAR MEDICINE, 2021, 21 (07) : 589 - 595
  • [34] Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm
    Torabi-Rahvar, Monireh
    Rezaei, Nima
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (13) : 1549 - 1552
  • [35] Molecular Biology of SARS-CoV-2
    Piepoli, Sofia
    Shamloo, Bahar
    Bircan, Aylin
    Adebali, Ogun
    Erman, Batu
    TURKISH JOURNAL OF IMMUNOLOGY, 2020, 8 (02): : 73 - 88
  • [36] Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak
    Griffin, Daniel O.
    Jensen, Alexandra
    Khan, Mushmoom
    Chin, Jessica
    Chin, Kelly
    Saad, Jennifer
    Parnell, Ryan
    Awwad, Christopher
    Patel, Darshan
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 : 90 - 92
  • [37] SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions
    Asrani, Purva
    Hassan, Md Imtaiyaz
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (02) : 675 - 687
  • [38] Immune response and cytokine storm in SARS-CoV-2 infection: Risk factors, ways of control and treatment
    Chegni, Hamid
    Babaii, Hadise
    Hassan, Zuhair M.
    Pourshaban, Manoochehr
    EUROPEAN JOURNAL OF INFLAMMATION, 2022, 20
  • [39] Suppression of miR-155 Attenuates Lung Cytokine Storm Induced by SARS-CoV-2 Infection
    Soni, Dharmendra Kumar
    Cabrera-Luque, Juan
    Kar, Swagata
    Ahmed, Anwar
    Sen, Chaitali
    Devaney, Joseph
    Biswas, Roopa
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2025, : 150 - 161
  • [40] Cytokine Response in SARS-CoV-2 Infection in the Elderly
    Sherwani, Subuhi
    Khan, Mohd Wajid Ali
    JOURNAL OF INFLAMMATION RESEARCH, 2020, 13 : 737 - 747
12345